UNSPSC 51183613: Insulin glulisine
Commodity
Code facts
- Part of
-
-
51000000
-
51180000
- 51183600
-
51180000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51183613
| NIGP code |
|---|
| 26968 Hormones and Synthetic Substitutes |
Definition
This classification denotes a therapeutic insulin with the molecular formula C258H384N64O78S6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7XIY785AZD, chemically known as insulin (ox), 8a-l-threonine-10a-l-isoleucine-30b-l-threonine- but more generally known as insulin, which bears US NIH Compound Identifier 16129672. European Medicines Agency schedules Insulin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02689MIG.
Read the full definition
The term INSULIN GLULISINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 15 No. 3-4, 2001, List 46) WHO schedules insulin in its Anatomical Therapeutic Chemical (ATC) Classification. INSULIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule Insulin glulisine under HS 29371900 and SITC 54154. SMILES:. As of Q4 2014, INSULIN GLULISINE remains US FDA's Preferred Term for this commodity..
Insulin glulisine bears US NLM identifiers UMLS ID C1313386 and NCI Concept Code C65921.
About UNSPSC 51183613
UNSPSC 51183613 Insulin glulisine is a Commodity code covering the procurement of this rapid-acting insulin analog by state and local health agencies, primarily Medicaid programs, state health departments, and public hospital systems that furnish diabetes care to uninsured and low-income populations. State and local buyers use this code to source insulin glulisine for outpatient dispensing, emergency department use, and inpatient hospital formularies. The drug is procured through a mix of direct purchase from manufacturers, group purchasing organization (GPO) contracts, and state Medicaid pharmaceutical benefit management (PBM) arrangements. Issuing bodies typically include state Medicaid agencies, county health departments, municipal hospital authorities, and regional health districts that maintain formularies or operate their own pharmacy operations.
The source provides no recent state and local contract opportunities tagged to UNSPSC 51183613 Insulin glulisine. Without posted RFP, RFQ, IFB, or ITB activity, geographic spread and near-term pursuit signals cannot be assessed from procurement records. Insulin procurement at the state and local level often flows through standing state Medicaid contracts, federal 340B pricing programs, or cooperative purchasing agreements negotiated at the state level rather than through individual solicitations, which may explain the absence of posted opportunities under this specific code. Business development professionals should monitor state Medicaid agency websites, GPO catalogs, and health department formulary updates for procurement signals in this category.
Quick answers
What is UNSPSC 51183613?
UNSPSC 51183613 is Insulin glulisine, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51183613?
UNSPSC 51183613 maps to 1 NIGP code, 26968 Hormones and Synthetic Substitutes.
On GovTribe
See everything under UNSPSC 51183613
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code